Screener
SELLAS Life Sciences Group, Inc. SLS Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
FAQ
- What is SELLAS Life Sciences Group, Inc.'s debt-to-equity?
- SELLAS Life Sciences Group, Inc. (SLS) reported debt-to-equity of 0× in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s debt-to-equity changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s debt-to-equity decreased by 74.1% year-over-year, from 0× to 0×.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s debt-to-equity?
- Over 4 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s debt-to-equity has grown at a -20.6% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about SELLAS Life Sciences Group, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude